Full Text Journal Articles by
Author Rodolfo Guerrero

Advertisement

Find full text journal articles








Effects of Serelaxin in Patients with Acute Heart Failure.

Marco Metra, John R Teerlink, Gad Cotter, Beth A Davison, G Michael Felker, Gerasimos Filippatos, Barry H Greenberg, Peter S Pang, Piotr Ponikowski, Adriaan A Voors, Kirkwood F Adams, Stefan D Anker, Alexandra Arias-Mendoza, Patricio Avendaño, Fernando Bacal, Michael Böhm, Guillermo Bortman, John G F Cleland, Alain Cohen-Solal, Maria G Crespo-Leiro, Maria Dorobantu, Luis E Echeverría, Roberto Ferrari, Sorel Goland, Eva Goncalvesová, Assen Goudev, Lars Køber, Juan Lema-Osores, Phillip D Levy, Kenneth McDonald, Pravin Manga, Béla Merkely, Christian Mueller, Burkert Pieske, Jose Silva-Cardoso, Jindřich Špinar, Iain Squire, Janina Stępińska, Walter Van Mieghem, Dirk von Lewinski, Gerhard Wikström, Mehmet B Yilmaz, Nicole Hagner, Thomas Holbro, Tsushung A Hua, Shalini V Sabarwal, Thomas Severin, Peter Szecsödy, Claudio Gimpelewicz, ,

BACKGROUND:Serelaxin is a recombinant form of human relaxin-2, a vasodilator hormone that contributes to cardiovascular and renal adaptations during pregnancy. Previous studies have suggested that treatment with serelaxin may result in relief of symptoms and in better outcomes in patients with acute heart failure. METHODS:In this multicenter, double-blind, placebo-controlled, event-driven ... Read more >>

N. Engl. J. Med. (The New England journal of medicine)
[2019, 381(8):716-726]

Cited: 0 times

View full text PDF listing >>



Global cPILOT analysis of the APP/PS-1 mouse liver proteome.

Adam R Evans, Liqing Gu, Rodolfo Guerrero, Renã A S Robinson,

A quantitative proteomics strategy called combined precursor isotopic labeling and isobaric tagging (cPILOT) was designed to discover alterations in the amyloid precursor protein/presenilin-1 (APP/PS-1) mouse liver proteome. The multiplexing strategy allows simultaneous quantitation of 12 samples in a single experiment.For cPILOT samples, six APP/PS-1 and six heterozygous mouse livers were ... Read more >>

Proteomics Clin Appl (Proteomics. Clinical applications)
[2015, 9(9-10):872-884]

Cited: 6 times

View full text PDF listing >>



Advertisement

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial.

Aldo P Maggioni, Stephen J Greene, Gregg C Fonarow, Michael Böhm, Faiez Zannad, Scott D Solomon, Eldrin F Lewis, Fabio Baschiera, Tsushung A Hua, Claudio R Gimpelewicz, Anastasia Lesogor, Mihai Gheorghiade, ,

AIMS: The objective of the Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) was to determine whether aliskiren, a direct renin inhibitor, would improve post-discharge outcomes in patients with hospitalization for heart failure (HHF) with reduced ejection fraction. Pre-specified subgroup analyses suggested potential heterogeneity in post-discharge outcomes with aliskiren in ... Read more >>

Eur. Heart J. (European heart journal)
[2013, 34(40):3117-3127]

Cited: 29 times

View full text PDF listing >>





Advertisement

Disclaimer
4.3763 s